PUBLICATIONS

FSP Model in Clinical Trials — Everything Sponsors Need to Know The global clinical outsourcing landscape is evolving rapidly. As trials become more complex, decentralized, and data-intensive, biopharma companies are rethinking how they build operational capacity. Across the industry, there is a clear shift toward more flexible, transparent, and scalable outsourcing structures—driven by the rising adoption of Functional Service Provider (FSP) partnerships. FSP models enable sponsors Read more

Five Insights Changing Alzheimer’s Care in 2025 Today, an estimated 57 million people are living with dementia, and around 60–70% of them have Alzheimer’s disease, the most common and devastating form of cognitive decline. In the U.S., Alzheimer’s has climbed to the sixth leading cause of death, surpassing breast and prostate cancers combined. And the challenge is only growing: by 2050, the Read more

Clinical Research Focus. 46th Edition Nobel Laureate Unveils Technique to Turn Rogue T Cells into Their Own Treatment Just weeks after receiving the 2025 Nobel Prize for discovering regulatory T cells, Shimon Sakaguchi and colleagues have published two Science Translational Medicine papers showing how disease-causing T cells can be reprogrammed into regulatory ones. The approach suppressed inflammation and autoimmune reactions Read more

ESMO 2025: Notes From the Floor — What Will Really Change Oncology in 2026 By Vlad Bogin, MD, FACP, CEO, Cromos Pharma The 2025 ESMO Congress, held in Berlin, brought together over 35,000 oncology professionals from around the world to showcase data that are already reshaping the clinical landscape. Below are the readouts I think will actually change clinical practice and influence the way sponsors design trials in 2026 Read more